Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01290809 : Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- UICC stage III A or III B (without malignant pleural or pericardial effusion)
non-small cell lung cancer

- Whole body PDG-PET scan before the start of therapy available: no distant metastasis.

- CT or preferably MRI of the brain before the start of radical therapy available; no
brain metastasis.

- Platinum-based chemotherapy is mandatory.

- Radical local therapy: concurrent or sequential chemotherapy and radiotherapy with or
without surgery.

- Radiotherapy dose without surgery to at least biological equivalent of 60 Gy.

- No prior cranial irradiation.sufficient proficiency in Dutch language

- sufficient proficiency in Dutch language

- MRI (and not CT scan) pre-PCI

Exclusion Criteria:

- none
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01290809      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740